Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ViraferonPeg 150microgram inj vials
0802040A0BBADAD
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj pre-filled pens
0802040A0BBAHAJ
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj pre-filled pens CLEARCLICK
0802040A0BBALAJ
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj vials
0802040A0BBACAC
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj pre-filled pens
0802040A0BBAJAL
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj pre-filled pens CLEARCLICK
0802040A0BBAKAL
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj vials
0802040A0BBAAAA
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Viralief 5% cream
1310030C0BGAAAA
|
Viralief | Aciclovir | Skin | No data available |
|
Viramune 100mg modified-release tablets
0503010B0BBADAD
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 200mg tablets
0503010B0BBAAAA
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 400mg modified-release tablets
0503010B0BBAEAE
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 50mg modified-release tablets
0503010B0BBACAC
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 50mg/5ml oral suspension
0503010B0BBABAB
|
Viramune | Nevirapine | Infections | No data available |
|
Virazole 1.2g/12ml solution for injection vials
0503050B0BCACAI
|
Virazole | Ribavirin | Infections | No data available |
|
Virazole 6g powder for nebuliser solution vials
0503050B0BCABAA
|
Virazole | Ribavirin | Infections | No data available |
|
Viread 123mg tablets
0503010H0BBACAC
|
Viread | Tenofovir disoproxil | Infections | No data available |
|
Viread 163mg tablets
0503010H0BBADAD
|
Viread | Tenofovir disoproxil | Infections | No data available |
|
Viread 204mg tablets
0503010H0BBAEAE
|
Viread | Tenofovir disoproxil | Infections | No data available |
|
Viread 33mg/g granules
0503010H0BBABAB
|
Viread | Tenofovir disoproxil | Infections | No data available |
|
Viroflu vacc inj 0.5ml pre-filled syringes
1404000H0BMAAAF
|
Viroflu | Influenza | Immunological Products and Vaccines | No data available |
|
Viroptic 1% eye drops
1103030T0BDAAAB
|
Viroptic | Trifluridine (Antivirals) | Eye | No data available |
|
Virormone 100mg/2ml solution for injection ampoules
0604020P0BBACAD
|
Virormone (Parenteral) | Testosterone propionate | Endocrine System | No data available |
|
Virovir 200mg tablets
0503021C0BCAAAB
|
Virovir | Aciclovir | Infections | No data available |
|
Virovir 400mg tablets
0503021C0BCABAC
|
Virovir | Aciclovir | Infections | No data available |
|
Virovir 800mg tablets
0503021C0BCACAD
|
Virovir | Aciclovir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.